Literature DB >> 29110608

The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.

Y Yu1,2, J Zhang1, R Zhu2, R Zhao1, J Chen1, J Jin1, Y Tian1, S B Su1.   

Abstract

OBJECTIVE: To explore the expression profile of angiogenic factors associated with proliferative diabetic retinopathy (PDR).
METHODS: Undiluted vitreous humor samples were obtained from 10 diabetic patients with PDR (10 eyes) and 9 non-diabtic patients (9 eyes). The concentrations of 60 angiogenic factors in the vitreous humor samples were measured by RayBio Angiogenic Cytokine Antibody Array. Some differentially expressed factors were further confirmed in vitreous humor by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Compared with the non-diabetic controls, 20 differentially expressed factors with more than 1.50 fold changes were detected in patients with PDR. The median concentration of vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), angiopoietin (ANG)-1, ANG-2, urokinase-type plasminogen activator receptor (uPAR), Follistatin and matrix metalloproteinases 9 (MMP-9) was significantly increased in vitreous samples from PDR compared to controls (P < 0.05). However, (MCP)-1, Angiogenin and Leptin was significantly lower in PDR eyes compared to controls (P < 0.05). In the verification assay using ELISA, ANG-1, ANG-2, IL-6, VEGF, MMP-9, hepatocyte growth factor (HGF) and placenta growth factor (PIGF) concentration were increased in patients with PDR compared to controls (all P-values < 0.05).
CONCLUSION: This is the first report of a comprehensive multiplex analysis to identify angiogenic factors associated with PDR. These angiogenic factors may contribute to the pathogenesis of PDR and may be targets for therapeutic strategies of PDR. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Diabetes; ELISA; angiogenesis; proliferative diabetic retinopathy; retinopathy; vitreous humor

Mesh:

Substances:

Year:  2017        PMID: 29110608     DOI: 10.2174/1566524017666171106111440

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  11 in total

Review 1.  Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Ryan H Mason; Samuel A Minaker; Gabriela Lahaie Luna; Priya Bapat; Armin Farahvash; Anubhav Garg; Nishaant Bhambra; Rajeev H Muni
Journal:  Eye (Lond)       Date:  2022-06-07       Impact factor: 4.456

2.  The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

Authors:  Megan E Capozzi; Sara R Savage; Gary W McCollum; Sandra S Hammer; Carla J Ramos; Rong Yang; Colin A Bretz; John S Penn
Journal:  Exp Eye Res       Date:  2019-11-20       Impact factor: 3.467

Review 3.  The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease.

Authors:  Siva S R Iyer; Mollie K Lagrew; Stephanie M Tillit; Ramak Roohipourmoallai; Samuel Korntner
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

4.  Mechanisms and Minimization of False Discovery of Metabolic Bioorthogonal Noncanonical Amino Acid Proteomics.

Authors:  Chao Liu; Nathan Wong; Etsuko Watanabe; William Hou; Leonardo Biral; Jonalyn DeCastro; Melod Mehdipour; Kiana Aran; Michael J Conboy; Irina M Conboy
Journal:  Rejuvenation Res       Date:  2022-04       Impact factor: 3.192

5.  Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS.

Authors:  Edward K Duran; Nancy R Cook; Maria Bobadilla; Eunjung Kim; JoAnn E Manson; Julie E Buring; Paul M Ridker; Aruna D Pradhan
Journal:  J Am Heart Assoc       Date:  2019-07-19       Impact factor: 5.501

Review 6.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

7.  Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations.

Authors:  Yousof Taghavi; Gholamhossein Hassanshahi; Nicholas G Kounis; Ioanna Koniari; Hossein Khorramdelazad
Journal:  J Cell Commun Signal       Date:  2019-01-03       Impact factor: 5.908

Review 8.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

9.  Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.

Authors:  Frances Wu; Audrey Phone; Ricardo Lamy; Dahui Ma; Sawarin Laotaweerungsawat; Yi Chen; Tong Zhao; Wei Ma; Fuyan Zhang; Catherine Psaras; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

Review 10.  Endothelial Dysfunction in Diabetic Retinopathy.

Authors:  Fu Gui; Zhipeng You; Shuhua Fu; Hongxi Wu; Yulan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.